128 related articles for article (PubMed ID: 25277815)
1. A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay.
Rosen O; Feldberg L; Gura S; Zichel R
Anal Biochem; 2015 Mar; 473():7-10. PubMed ID: 25277815
[TBL] [Abstract][Full Text] [Related]
2. Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assay.
Rosen O; Feldberg L; Dor E; Gura S; Zichel R
Anal Biochem; 2017 Jul; 528():34-37. PubMed ID: 28450105
[TBL] [Abstract][Full Text] [Related]
3. Improved detection of botulinum type E by rational design of a new peptide substrate for endopeptidase-mass spectrometry assay.
Rosen O; Feldberg L; Gura S; Zichel R
Anal Biochem; 2014 Jul; 456():50-2. PubMed ID: 24721293
[TBL] [Abstract][Full Text] [Related]
4. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.
Wang D; Baudys J; Ye Y; Rees JC; Barr JR; Pirkle JL; Kalb SR
Anal Biochem; 2013 Jan; 432(2):115-23. PubMed ID: 23017875
[TBL] [Abstract][Full Text] [Related]
5. Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.
Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
Bioorg Med Chem; 2015 Jul; 23(13):3667-73. PubMed ID: 25913863
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin detection and differentiation by mass spectrometry.
Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of botulinum neurotoxin type A in stool by mass spectrometry.
Wang D; Baudys J; Kalb SR; Barr JR
Anal Biochem; 2011 May; 412(1):67-73. PubMed ID: 21276417
[TBL] [Abstract][Full Text] [Related]
8. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
[TBL] [Abstract][Full Text] [Related]
9. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry.
Boyer AE; Moura H; Woolfitt AR; Kalb SR; McWilliams LG; Pavlopoulos A; Schmidt JG; Ashley DL; Barr JR
Anal Chem; 2005 Jul; 77(13):3916-24. PubMed ID: 15987092
[TBL] [Abstract][Full Text] [Related]
10. Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry.
Wang D; Baudys J; Hoyt KM; Barr JR; Kalb SR
Anal Bioanal Chem; 2017 Aug; 409(20):4779-4786. PubMed ID: 28573317
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization.
Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR
Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236
[TBL] [Abstract][Full Text] [Related]
12. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry.
Parks BA; Shearer JD; Baudys J; Kalb SR; Sanford DC; Pirkle JL; Barr JR
Anal Chem; 2011 Dec; 83(23):9047-53. PubMed ID: 22017298
[TBL] [Abstract][Full Text] [Related]
13. Characterization of botulinum neurotoxin type A subtypes by immunocapture enrichment and liquid chromatography-tandem mass spectrometry.
Morineaux V; Mazuet C; Hilaire D; Enche J; Popoff MR
Anal Bioanal Chem; 2015 Jul; 407(19):5559-70. PubMed ID: 26038189
[TBL] [Abstract][Full Text] [Related]
14. A simple, rapid and sensitive FRET assay for botulinum neurotoxin serotype B detection.
Guo J; Xu C; Li X; Chen S
PLoS One; 2014; 9(12):e114124. PubMed ID: 25437190
[TBL] [Abstract][Full Text] [Related]
15. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
16. Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism.
Lévêque C; Ferracci G; Maulet Y; Mazuet C; Popoff M; Seagar M; El Far O
Biosens Bioelectron; 2014 Jul; 57():207-12. PubMed ID: 24583693
[TBL] [Abstract][Full Text] [Related]
17. A graphene oxide based fluorescence resonance energy transfer (FRET) biosensor for ultrasensitive detection of botulinum neurotoxin A (BoNT/A) enzymatic activity.
Shi J; Guo J; Bai G; Chan C; Liu X; Ye W; Hao J; Chen S; Yang M
Biosens Bioelectron; 2015 Mar; 65():238-44. PubMed ID: 25461164
[TBL] [Abstract][Full Text] [Related]
18. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics.
Kalb SR; Goodnough MC; Malizio CJ; Pirkle JL; Barr JR
Anal Chem; 2005 Oct; 77(19):6140-6. PubMed ID: 16194071
[TBL] [Abstract][Full Text] [Related]
19. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
[TBL] [Abstract][Full Text] [Related]
20. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
Schmidt JJ; Stafford RG
Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
